Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy.
Cressey
Tim R
TR
Leenasirimakul
Prattana
P
Jourdain
Gonzague
G
Tawon
Yardpiroon
Y
Sukrakanchana
Pra-Ornsuda
PO
Lallemant
Marc
M
D023241:Antiretroviral Therapy, Highly Active; D019540:Area Under Curve; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D006207:Half-Life; D006801:Humans; D017410:Practice Guidelines as Topic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D015215:Zidovudine / Q000008:administration & dosage / Q000493:pharmacokinetics*
D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine